Drug repurposing - identifying new uses for existing medications- has emerged as a transformative approach in oncology, offering a cost-effective and ...

LIVERMORE — Lawrence Livermore National Laboratory (LLNL) scientists are making progress with high-performance computing machines, including the supercomputer Tuolumne, and a tailored artificial intel ...

On July 31, medical artificial intelligence (AI) company Lunit announced plans to develop a personalized AI-based integrated ...

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...

Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com ...

Researchers integrated machine learning with multi-tiered validation to identify FDA-approved non-lipid-lowering drugs with lipid-modifying potential. From 3,430 drugs screened, 29 candidates emerged.

Cancer continues to be a substantial global health issue. By customizing prevention, diagnosis, and treatment plans depending on individual patient genetic ...

GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

When big infrastructure projects spring up, one crucial law — the National Environmental Policy Act — has for decades been a ...

Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is one of the Stocks With Huge Catalysts on the Horizon. On July 25, KalVista ...